Validation pour Ingenuity085

vers la météo de la validation par utilisateur

Ingenuity085

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 10 - PMID ?

Endometriosis in female mid secretory phase SP is associated with downregulation of SP NODE mRNA in endometrium from female mid secretory phase SP exhibiting endometriosis .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 1

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 2

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 3

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 4

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 5

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 6

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 7

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 8

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                 +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 9

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                 +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 10

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+                         |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |                         |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 11

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+                         |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |                         |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 12

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 13

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 14

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 15

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +--------MOD_ATT:N-N-------+                                                          |                         +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 16

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 17

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 18

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 19

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 20

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 21

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 22

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                             |                                                      +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 23

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +--------MOD_ATT:N-N-------+                             |                                                      +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 24

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +-------MOD_ATT:N-ADJ------+                                                                                    +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 25

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +--------MOD_ATT:N-N-------+                                                                                    +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 26

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |          |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 27

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |          |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 28

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 29

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |                         +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 30

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 31

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 32

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 33

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 34

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 35

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 36

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 37

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 38

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 39

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 40

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 41

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 42

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 43

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 44

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 45

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 46

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 47

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 48

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 49

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 50

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 51

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 52

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                                                                        |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 53

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                                                                        |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 54

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 55

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 56

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 57

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 58

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                 +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 59

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                 +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 60

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 61

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 62

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+                         |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |                         |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 63

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                 +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |                 |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+                         |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |                         |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 64

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 65

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 66

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 67

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 68

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 69

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 70

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 71

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 72

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 73

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +--------MOD_ATT:N-N-------+                                                          |                         +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 74

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 75

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +--------MOD_ATT:N-N-------+                                                          |                         +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 76

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 77

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +--------MOD_ATT:N-N-------+                                                          |                         +-------MOD_ATT:N-ADJ------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 78

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 79

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 80

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 81

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 82

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 83

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 84

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                             |                                                      +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 85

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +--------MOD_ATT:N-N-------+                             |                                                      +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 86

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 87

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 88

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +-------MOD_ATT:N-ADJ------+                                                                                    +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 89

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +--------MOD_ATT:N-N-------+                                                                                    +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 90

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 91

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 92

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |          |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 93

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |          |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 94

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |          |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 95

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |          |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 96

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |          |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 97

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |          |              +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 98

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 99

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |                         +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 100

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 101

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 102

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 103

       +---------------MOD_ATT:N-N--------------+                             +----------------------------------COMP:N-N(from)---------------------------------+                             
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
COMP:N-N(from) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 104

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 105

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |                         +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 106

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 107

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 108

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +-------MOD_ATT:N-ADJ------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 109

       +---------------MOD_ATT:N-N--------------+                                                                                                                                             
       |             +--------MOD_ATT:N-N-------+                             +--------------COMP:N-N(in)-------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                             +--------COMP:N-N(of)--------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                             |             +-MOD_ATT:N-ADJ+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             |       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |                 |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:N-N(of) (downregulation,mRNA)
COMP:N-N(in) (downregulation,endometrium)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 110

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 111

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |                         +-------MOD_ATT:N-ADJ------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 112

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 113

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 114

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 115

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 116

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 117

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 118

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 119

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 120

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                                                                        |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 121

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |                                                                        |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 122

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +-------MOD_ATT:N-ADJ------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 123

       +---------------MOD_ATT:N-N--------------+           +----------------------------------------COMP:V_PASS-N(from)----------------------------------------+                             
       |             +--------MOD_ATT:N-N-------+           |                                                                        +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(from) (associate,__SP__)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 124

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 125

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           +--------------------COMP:V_PASS-N(in)--------------------+              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 126

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 127

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+           +--------------------COMP:V_PASS-N(in)--------------------+              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+           |       +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+           |       |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      |          |              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
COMP:V_PASS-N(in) (associate,endometrium)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 128

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 129

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 130

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 131

       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+                             
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 132

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 133

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +--------MOD_ATT:N-N-------+                                                          |                         +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 134

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 135

       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+                             
       |             +--------MOD_ATT:N-N-------+                                                          |                         +--------MOD_ATT:N-N-------+                             
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+                             
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+                             
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+SUBJ:V-N+--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,__SP__)
OBJ:V-N (exhibit,endometriosis)

Analyse 136

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 137

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                                     |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 138

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 139

                                                                                                                      +---------------------SUBJ:V-N---------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                                     +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                                     |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,endometrium)
OBJ:V-N (exhibit,endometriosis)

Analyse 140

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |          |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 141

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |          |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 142

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |          |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 143

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          |          +--------------COMP:N-N(from)-------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |          |              +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+          |              |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |          |              |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (endometrium,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 144

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 145

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |                         +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                                                          |                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   +----------------OBJ:V-N---------------+                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+-COMP:N-N(of)+       +MOD_AT+COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 146

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +-------MOD_ATT:N-ADJ------+                                                          |                         +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)

Analyse 147

                                                                                                           +---------------------------SUBJ:V-N--------------------------+                    
       +---------------MOD_ATT:N-N--------------+                                                          +-------------------COMP:N-N(from)-------------------+        |                    
       |             +--------MOD_ATT:N-N-------+                                                          |                         +--------MOD_ATT:N-N-------+        |                    
       |             |    +----MOD_ATT:N-ADJ----+                   +----------------OBJ:V-N---------------+                         |    +----MOD_ATT:N-ADJ----+        |                    
       |             |    |      +-MOD_ATT:N-ADJ+                   |         +-----COMP:N-N(of)----+      |                         |    |      +-MOD_ATT:N-ADJ+        |                    
       |             |    |      |       +MOD_AT+SUBJ:V_PASS+COMP:V_PASS-N(wit+             +MOD_ATT+      +COMP:N-N(i+              |    |      |       +MOD_AT+        +--OBJ:V-N--+        
       |             |    |      |       |      |           |       |         |             |       |      |          |              |    |      |       |      |        |           |        
 Endometriosis in female mid secretory phase __SP__ is associated with downregulation of __SP__ __NODE__ mRNA in endometrium from female mid secretory phase __SP__ exhibiting endometriosis .
MOD_ATT:N-N (__SP__,endometriosis)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V_PASS-N (associate,__SP__)
COMP:V_PASS-N(with) (associate,downregulation)
OBJ:V-N (with,mRNA)
COMP:N-N(of) (downregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,endometrium)
COMP:N-N(from) (mRNA,__SP__)
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-ADJ (__SP__,mid)
MOD_ATT:N-ADJ (__SP__,secretory)
MOD_ATT:N-N (__SP__,phase)
SUBJ:V-N (exhibit,mRNA)
OBJ:V-N (exhibit,endometriosis)